ECG Findings in Coronary Artery Disease and Associated Arrhythmias
The ECG in coronary artery disease demonstrates specific patterns of acute ischemia/infarction including ST-segment elevation ≥0.1 mV in two contiguous leads (≥0.2 mV in men ≥40 years or ≥0.25 mV in men <40 years in leads V2-V3), ST-segment depression ≥0.05 mV, T-wave inversions, and pathological Q waves, while arrhythmias correlate directly with the severity of left ventricular dysfunction rather than the degree of coronary stenosis. 1
Acute Ischemia/Infarction ECG Patterns
ST-Segment Elevation (STEMI)
- New ST elevation at the J point in two contiguous leads:
- ≥0.1 mV in all leads except V2-V3
- In leads V2-V3: ≥0.2 mV in men ≥40 years; ≥0.25 mV in men <40 years; ≥0.15 mV in women 1
- Prolonged ST elevation (>20 minutes), particularly with reciprocal ST depression, reflects acute coronary occlusion with myocardial necrosis 1
ST-Segment Depression and T-Wave Changes
- New horizontal or down-sloping ST depression ≥0.05 mV in two contiguous leads 1
- T-wave inversion ≥0.1 mV in two contiguous leads with prominent R wave or R/S ratio >1 1
- More profound ST-segment shifts or T-wave inversions involving multiple leads indicate greater myocardial ischemia and worse prognosis 1
High-Risk ECG Patterns Requiring Immediate Recognition
Deeply inverted T waves (>0.5 mV) in leads V2-V4 with QT prolongation indicate severe proximal left anterior descending artery stenosis with high risk of anterior wall infarction if untreated 2. This pattern mimics the CVA (cerebrovascular accident) pattern and demands urgent angiography.
Lead aVR ST-segment elevation suggests left main or proximal left anterior descending disease and carries significant short- and long-term mortality risk 3.
Territory-Specific ECG Findings
Posterior (Inferolateral/Basal-Lateral) Infarction
- ST depression in leads V1-V2, especially with positive terminal T waves 2, 1
- Use posterior leads (V7-V9 at fifth intercostal space): ST elevation ≥0.05 mV (≥0.1 mV in men <40 years) 1
- Critical pitfall: Posterior ischemia is frequently overlooked; always obtain posterior leads when initial ECG is non-diagnostic with high clinical suspicion 1
Inferior Wall Ischemia/Infarction
- Cannot distinguish RCA vs LCx occlusion when inferior changes accompany ST depression in V1-V3 2
- LCx occlusion: ST elevation greater in lead II than III, may show isoelectric or elevated ST in leads I and aVL 2
- RCA occlusion: Absence of V1-V3 depression more suggestive 2
Prior Infarction ECG Criteria
Pathological Q Waves
- Leads V2-V3: Q wave ≥0.02 sec or QS complex 1
- Leads I, II, aVL, aVF, V4-V6: Q wave ≥0.03 sec and ≥0.1 mV deep or QS complex in any two contiguous leads 1
R Wave Abnormalities
- R wave ≥0.04 sec in V1-V2 with R/S ≥1 and concordant positive T wave (absent conduction defect) suggests posterior infarction 1
Conduction Abnormalities in CAD
Left Bundle Branch Block (LBBB)
- Sgarbossa criteria for acute MI in LBBB:
Right Bundle Branch Block and Fascicular Blocks
- ST-segment criteria for acute ischemia/infarction remain unaffected by RBBB or fascicular blocks 2
QRS Prolongation
- QRS >180 ms strongly predicts ventricular arrhythmias (OR 22.23) in structural heart disease 4
- QRS >100 ms associates with greater left ventricular mass and chamber dilation 5
Arrhythmias in Coronary Artery Disease
Critical Relationship: Ventricular Dysfunction Over Stenosis Severity
Ventricular arrhythmias correlate with left ventricular dysfunction (akinesis with systolic shortening <15%) rather than the degree of coronary stenosis. 6 Patients with three-vessel disease show a tendency toward more ectopic beats, but the strongest predictor is ventricular akinesis, which significantly increases both congestive heart failure and life-threatening arrhythmias 6.
Ventricular Arrhythmias
- Incidence: 82% of CAD patients demonstrate ventricular premature beats (VPBs) on long-term ECG monitoring 6
- High-risk features:
- Fragmented QRS: 65.4% prevalence in patients with ventricular arrhythmias vs 37.2% without (P=0.022) 5
- Epsilon waves: 23.1% vs 2.3% (P=0.005), OR 14.33 for ventricular arrhythmias 5, 4
- Decreased ejection fraction and fractional shortening 5
- Elevated left ventricular end-diastolic pressure, decreased cardiac index 6
Atrial Arrhythmias
- Sinus node artery non-visualization occurs in 36% of patients with atrial arrhythmias (sinus bradycardia, atrial fibrillation, atrial premature beats) 7
- Generally associated with mild-to-moderate coronary stenosis compared to ventricular arrhythmias 7
Conduction Defects
- Severe stenosis of multiple coronary vessels predicts intraventricular conduction defects 7
- AV node artery non-visualization in 50% of patients with conduction defects 7
- Complete AV block: AV node artery not visualized from either right or left coronary injection 7
QTc Prolongation
- QTc >440 ms associates with elevated BNP, creatinine, and decreased eGFR 5
- Multivariate analysis shows significant relationship between QTc, age, and creatinine 5
- Combined with deep T-wave inversion suggests critical proximal LAD stenosis 2
Additional ECG Manifestations of Ischemia
Beyond standard ST-segment changes, recognize these less common but equally important signs 8:
- ST-segment alternans
- U-wave inversion
- Intraventricular conduction abnormalities developing during ischemia
- Loss of precordial R-wave amplitude 1
Clinical Integration
The ECG alone is insufficient for diagnosis—always compare to prior tracings and integrate with clinical presentation 1. ST deviation occurs in non-ischemic conditions including acute pericarditis, LVH, LBBB, Brugada syndrome, stress cardiomyopathy, and early repolarization 1.
Timing of ECG acquisition: Obtain within 10 minutes of presentation; repeat at 15-30 minute intervals if initial ECG is non-diagnostic in symptomatic patients; use continuous 12-lead monitoring when available 1.
Serious arrhythmias (94% tachycardias or increased myocardial irritability) increase significantly with greater ST-segment depression: 54% with ST depression >0.1 mV vs 24% with <0.05 mV 9. These warrant consideration of beta-blocker therapy 9.